Reduction of unnecessary central line utilization creates opportunity for value-based decisions and improves patient outcomes in vascular access.
The POWERWAND product line is a midline and extended dwell catheter supported by multiple peer reviewed papers scientific posters. This clinical evidence has documented over 36,000 catheter-days with zero bloodstream infections and a high completion of therapy (one-stick hospitalization).
The upcoming aptitude2020, designed to provide the busy hospital employee with information on emerging topics quickly, is proud to present Access Scientific on Wednesday, November 20th at 11:30 AM central/ 12:30 PM eastern – featuring a 20-minute presentation followed by 20 minutes for questions.
During this webinar, attendees will hear how hospitals using the POWERWAND have demonstrated the ability to reduce overall central line usage and a special offer which guarantees reduction of PICC usage if implementing the POWERWAND. To learn more about this product line, register today.